New patent for Global Blood drug OXBRYTA

Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are seven patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…


New patent for Clovis Oncology drug RUBRACA

Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Clovis Oncology drug RUBRACA appeared first on DrugPat…


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!